Tikva Allocell Pte Ltd

Tikva Allocell Pte Ltd

Biotechnology Research

Biopolis, Singapore 852 followers

An allogeneic EBV Virus Specific CAR T-Cell developer targeting high unmet medical need patients with solid tumors.

About us

Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Biopolis, Singapore
Type
Privately Held
Founded
2023
Specialties
CART, Cell & Gene Therapy, Clinical Trials, and Drug Discovery

Locations

  • Primary

    61 Biopolis Drive

    #03-09

    Biopolis, Singapore 138673, SG

    Get directions

Employees at Tikva Allocell Pte Ltd

Updates

Similar pages